* DNA THERAPEUTICS *
2006 - IDF
Évry
(near Paris)
www.dna-therapeutics.com Discovery, Drugs
Key words: Cancer, siDNA, DNA repair
Mission: to develop proprietary siDNA (signal interfering DNA) technology platform and molecules, interfering with DNA damage repair mechanisms, to fight treatment-resistant cancers
Clients: Prescribers
contact@dna-therapeutics.com
Age: 3 year(s)
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Personal venture |
Managing Dir.-CEO: Sun (Jian Sheg) [born 1959, also board chairman, Ph.D.]
Sc.Dir.-CSO: Sun (Jian Sheg)
Fin.Dir.-CFO:
BusDev:
Financers (Hist.): privately owned | Turnover (M€) : n.a.
Total funding (M€) : 3.4
Last funding (M€) : 2.2
Focus : Cancers
Position : Preclin
Company confirm : none |
History | DATE | MILESTONE | TYPE | TIME | | 2010 .01 | Patent (2nd) : granted on siDNA by USPTA (further secures the development of its lead product Dbait) | LEGAL | [3 years] |
| 2009 .07 | Financing (no interest loan) : 0.55 M€, by OSEO, to support CMC development of Dbait | DEBT | [3 years] |
| 2009 .02 | Research : publication in Clinical Cancer Research on Small-molecular drugs mimicking DNA damage (Dbait): a new strategy for sensitizing tumors to radiotherapy | R&D | [2 years] |
| 2009 .01 | 1st round-financing : 2.2 M€, led by SGAM SEFTI with 2 previous seed investors, Blue Medical Investments and G1J-Île de France | RFINA | [2 years] |
| 2008 .09 | Seed financing : 0.8 M€, led by Inserm Transfer Initiative, with G1J-Île de France, Blue Medical Investment Group and International Business Angels (parallely to a patent granted on SiDNA) | SFIN | [2 years] |
| 2007 .05 | Patent : granted on siDNA by USPTA (secures the development of its lead product Dbait) | LEGAL | [0 year] |
| 2006 .05 | Company founded by Prof. Jian Sheg Sun, from concepts elaborated by Jean-Marc Cosset and Marie Dutreix, in 2001 | ORGF | [0 year] | Actualisation / Updating: 07-Sept-2009 |
|
